Nonpulmonary medical complications in the intermediate and long-term survivor (Q41502338)

1 October 2017

1 reference

title

Nonpulmonary medical complications in the intermediate and long-term survivor (English)

1 reference

1 October 2017

Maurer JR

1 reference

1 October 2017

Tewari S

series ordinal

1 reference

1 October 2017

language of work or name

1 reference

1 June 1997

1 reference

Clinics in Chest Medicine

1 October 2017

published in

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

page(s)

367-382

1 reference

Severe osteoporosis before and after lung transplantation

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Osteopenia in adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Colon perforation after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Cyclosporine-associated hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Chronic exposure to cyclosporine affects endothelial and smooth muscle reactivity in the rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Corticosteroids contribute to muscle weakness in chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Cyclosporin A, methylprednisolone, and convulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Clinical management of pulmonary disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Respiratory steroid myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

The immunobiology and clinical use of current immunosuppressive therapy for renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

The prevalence, course, and characteristics of chronic anemia after heart and lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Rapid loss of vertebral mineral density after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

The adverse impact of cyclosporine on serum lipids in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Severe hemolysis due to a donor anti-D antibody after heart-lung transplantation. Association with lung and blood chimerism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Deep venous thrombosis and pulmonary embolism after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Factors influencing the development of hypercholesterolemia after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Osteoporosis and bone morbidity in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Rapidly evolving myopathy with myosin-deficient muscle fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Renal hemodynamics after lung transplantation. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

The incidence of renal failure in one hundred consecutive heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Protection against cyclosporine-induced impairment of renal microcirculation by verapamil in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Cyclosporine-induced sympathetic activation and hypertension after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Osteoporosis after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Myopathy and prolonged neuromuscular blockade after lung transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

1 reference

7 January 2021

The effects of pravastatin on hyperlipidemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

Cyclosporine nephrotoxicity in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970385-3

7 January 2021

10.1016/S0272-5231(05)70385-3

Identifiers

DOI

1 reference

release_tln4k3mo4zbopedkzmxdt5dkeq

1 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tln4k3mo4zbopedkzmxdt5dkeq

24 November 2022

mapped directly with Wikidata item

1 reference